BaggeEBrooksP. Osteoarthritis in older patients: Optimum treatment. Drugs Aging1995;7:176–83.
3.
MagaroMAltomonteLZoliAMironeLBerchicciMCTricerriAAsymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with nonsteroidal antiinflammatory drugs. Panminerva Med1989;31:16–8.
4.
VestalRE. Geriatric clinical pharmacology: An overview. In: VestalRE, ed. Drug therapy in the elderly. Sydney, Australia: ADIS Health Science Press, 1984:12–28.
5.
LibertiL. Glucosamine. In: HagemannRCBurnhamRHGranickBNeubauerD, eds. The review of natural products. St. Louis: Facts and Comparisons, 1996:1–2.
6.
BarclayTSTsourounisCMcCartGM. Glucosamine: A critical review of the literature. Ann Pharmacother1998;32:574–9.
7.
da CamaraCCDowlessGV. Glucosamine sulfate for osteoarthritis. Ann Pharmacother1998;32:580–7.
8.
ReicheltAForsterKKFischerMRovatiLCSetnikarI. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneimittelforschung1994;44:75–80.
9.
VazAL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin1982;8:145–9.
10.
HochbergMCAltmanRDBrandtKDClarkBMDieppePAGriffinMRGuidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum1995;38:1541–6.
11.
BloomBS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med1988;84(suppl 2A):20–4.
12.
GabrielSEJaakkimainenLBombardierC. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis. Ann Intern Med1991;115:787–96.
13.
JohnsonAGDayRO. The problems and pitfalls of NSAID therapy in the elderly (part I). Drugs Aging1991;1:130–43.
